Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for use in ALS.
“I really didn’t think anything of it at the time,” he said.
Stavenhagen launched Her ALS Story in April 2021, about two years after she was diagnosed with the terminal neurodegenerative ...
Analisa Novak is a content producer for CBS News and the Emmy Award-winning "CBS Mornings." She specializes in covering live events and exclusive interviews for the show. Analisa is a United States ...
Being diagnosed with ALS has changed many of the assumptions that columnist Justin Ramirez had about fatherhood, but he still remains "Dad." ...
Amyotrophic lateral sclerosis, or ALS, is a rare nervous system disease. Here's what we know this disease WHO's Jeriann ...
A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic ...